Fluticasone (Flovent) and mometasone (Asmanex) belong to which category of medications?

Fluticasone (Flovent) and mometasone (Asmanex) are classified as inhalable corticosteroids. These medications are primarily used in the management of asthma and other chronic respiratory conditions by reducing inflammation in the airways. Corticosteroids work by inhibiting various inflammatory pathways, leading to decreased mucus production and swelling, which helps improve airflow and decrease symptoms such as wheezing, coughing, and shortness of breath.

The mechanism of action for inhaled corticosteroids involves targeting the underlying inflammation that characterizes asthma. By reducing this inflammation, these medications help prevent asthma attacks and are often used as maintenance therapy. It’s important to note that inhaled corticosteroids do not provide immediate relief of acute symptoms; rather, they help control chronic symptoms when used consistently over time.

Inhalable corticosteroids stand in contrast to other categories of respiratory medications. Long-acting beta agonists (LABAs) and short-acting beta agonists are bronchodilators that work by relaxing the muscles of the airways to improve airflow, but they do not address inflammation. Leukotriene modifiers work by blocking the action of leukotrienes—substances that contribute to inflammation, bronchoconstriction, and mucus production—but they are a